PL101248B1 - Sposob wytwarzania nowych pochodnych piroliny - Google Patents

Sposob wytwarzania nowych pochodnych piroliny Download PDF

Info

Publication number
PL101248B1
PL101248B1 PL1975199797A PL19979775A PL101248B1 PL 101248 B1 PL101248 B1 PL 101248B1 PL 1975199797 A PL1975199797 A PL 1975199797A PL 19979775 A PL19979775 A PL 19979775A PL 101248 B1 PL101248 B1 PL 101248B1
Authority
PL
Poland
Prior art keywords
methylene chloride
chloro
piperazinyl
naphthyridinyl
keto
Prior art date
Application number
PL1975199797A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7436963A external-priority patent/FR2313060A1/fr
Priority claimed from FR7527160A external-priority patent/FR2322600A1/fr
Priority claimed from FR7527162A external-priority patent/FR2322602A1/fr
Priority claimed from FR7527161A external-priority patent/FR2322601A1/fr
Application filed filed Critical
Publication of PL101248B1 publication Critical patent/PL101248B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL1975199797A 1974-11-07 1975-11-07 Sposob wytwarzania nowych pochodnych piroliny PL101248B1 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR7436963A FR2313060A1 (fr) 1974-11-07 1974-11-07 Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent
FR7527160A FR2322600A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de la pyrrolo (3,4-b) pyrazine, leur preparation et les compositions qui les contiennent
FR7527162A FR2322602A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de l'oxathiinno- et du dithiinnopyrrole, leur preparation et les compositions qui les contiennent
FR7527161A FR2322601A1 (fr) 1975-09-04 1975-09-04 Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
PL101248B1 true PL101248B1 (pl) 1978-12-30

Family

ID=27446274

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1975199797A PL101248B1 (pl) 1974-11-07 1975-11-07 Sposob wytwarzania nowych pochodnych piroliny

Country Status (27)

Country Link
US (1) US4220646A (en:Method)
JP (2) JPS5422996B2 (en:Method)
AR (2) AR208414A1 (en:Method)
AT (2) AT343123B (en:Method)
AU (1) AU503200B2 (en:Method)
BE (1) BE835325A (en:Method)
CA (1) CA1057755A (en:Method)
CH (1) CH609057A5 (en:Method)
CS (2) CS231957B2 (en:Method)
CY (1) CY1045A (en:Method)
DD (1) DD122684A5 (en:Method)
DE (1) DE2550111C2 (en:Method)
DK (1) DK141098B (en:Method)
FI (1) FI60707C (en:Method)
GB (1) GB1468497A (en:Method)
HK (1) HK19380A (en:Method)
HU (1) HU173108B (en:Method)
IE (1) IE41928B1 (en:Method)
IL (1) IL48423A (en:Method)
LU (1) LU73738A1 (en:Method)
NL (1) NL177405C (en:Method)
NO (1) NO143576C (en:Method)
OA (1) OA05162A (en:Method)
PL (1) PL101248B1 (en:Method)
SE (1) SE407063B (en:Method)
SU (2) SU673173A3 (en:Method)
YU (2) YU39583B (en:Method)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2371198A2 (fr) * 1976-11-22 1978-06-16 Rhone Poulenc Ind Nouveaux derives du dithiepinno (1,4)(2,3-c) pyrrole, leur preparation et les compositions qui les contiennent
US4533751A (en) * 1981-10-09 1985-08-06 Scm Corporation Preparation of 1,3-dienamines from myrcene and substituted myrcene
FR2525606A1 (fr) * 1982-04-22 1983-10-28 Rhone Poulenc Sante Nouveaux derives du dithiino (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent
FR2607506B1 (fr) * 1986-12-02 1989-01-06 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2607504B1 (fr) * 1986-12-02 1989-01-27 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2671800B1 (fr) * 1991-01-17 1993-03-12 Rhone Poulenc Rorer Sa Derive de la 5h-pyrrolo[3,4-b]pyrazine optiquement actif, sa preparation et les compositions pharmaceutiques qui le contiennent.
US5786357A (en) 1991-12-02 1998-07-28 Sepracor Inc. Methods and compositions for treating sleep disorders, convulsive seizures and other disorders using optically pure (+) zopiclone
HU214331B (hu) * 1992-06-17 1998-03-02 Gyógyszerkutató Intézet Kft. Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
TW279864B (en:Method) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv
AU6956394A (en) * 1993-06-04 1995-01-03 Henkel Corporation Polymerizable compounds
US5922820A (en) * 1993-06-04 1999-07-13 Henkel Corporation Polymerizable compounds
US5565567A (en) * 1993-06-04 1996-10-15 Henkel Corporation. Polymerizable N,N'-substituted piperazine acrylamide compounds
CN1160398A (zh) 1994-09-23 1997-09-24 阿瑞斯药物公司 治疗肥大细胞炎性疾病的组合物和方法
US5663357A (en) 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5756742A (en) * 1995-12-22 1998-05-26 Henkel Corporation Polymerizable compounds
US6339086B1 (en) * 1999-05-14 2002-01-15 Swpracor, Inc. Methods of making and using N-desmethylzopiclone
EP1396493A4 (en) * 2001-04-26 2005-08-03 Ajinomoto Kk HETEROCYCLIC COMPOUNDS
PT1490363E (pt) 2002-03-29 2006-06-30 Indevus Pharmaceuticals Inc Processos de preparacao da 2-(7-cloro-1,8-naftiridina-2-il)-3-(5-metil-2-oxo-hexil)-1-isoindolinona
AU2003285012A1 (en) * 2002-10-24 2004-05-13 Sepracor, Inc. Compositions comprising zopiclone derivatives and methods of making and using the same
AR042194A1 (es) * 2002-11-22 2005-06-15 Merck & Co Inc Metodo para preparar inhibidores de fosfodiesterasa - 4
US6909002B2 (en) * 2002-11-22 2005-06-21 Merck & Co., Inc. Method of preparing inhibitors of phosphodiesterase-4
UA79518C2 (en) * 2002-11-22 2007-06-25 Merck & Co Inc Process for preparation of phosphodiesterase-4 inhibitors
WO2005060968A1 (en) 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
US20050232983A1 (en) * 2004-04-14 2005-10-20 Indevus Pharmaceuticals, Inc. Transdermal patch
CA2614209A1 (en) * 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and o-desmethylvenlafaxine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
JP2009500425A (ja) 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
WO2007025177A2 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20080305171A1 (en) * 2007-06-07 2008-12-11 Kristin Anne Arnold Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there
CN100569775C (zh) * 2007-12-19 2009-12-16 齐鲁天和惠世制药有限公司 佐匹克隆的晶型转换的方法
WO2010088385A1 (en) 2009-01-30 2010-08-05 Sepracor Inc. Coated tablets of 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5h-pyrrol o [3,4-b] pyrazine and methods for measuring effectiveness of coating
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
JP6984656B2 (ja) * 2017-05-25 2021-12-22 信越化学工業株式会社 フルオロポリエーテル基含有ポリマー変性有機ケイ素化合物、表面処理剤及び物品
CN108129476A (zh) * 2017-11-27 2018-06-08 华中农业大学 一种杂环内酰胺衍生物及其用于作物病原菌杀菌剂的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1312427A (fr) * 1961-04-12 1962-12-21 Science Union Et Compagnie Soc Nouveaux dérivés de la pipérazine et leurs préparations
FR2101081B1 (en:Method) * 1970-08-19 1974-01-11 Rhone Poulenc Sa
BE790408A (fr) * 1971-10-22 1973-04-20 Rhone Poulenc Sa Nouveaux derives de la pyrrolo (3,4-b) pyridine, leur preparation et les compositions medicinales qui les
OA04285A (fr) * 1972-01-07 1979-12-31 Rhone Poulenc Sa Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
BE793851A (fr) * 1972-01-10 1973-07-10 Rhone Poulenc Sa Nouveaux derives de l'isoindoline, leur preparation et les compositions medicinales qui les contiennent
AR207555A1 (es) * 1972-12-04 1976-10-15 Procedimiento para preparar aril-6-piperazinocarboniloxi-5 oxo-7 tetrahidro-2,3,6,7 ditiino(1,4)(2,3-c)pirroles
OA04700A (fr) * 1973-05-15 1980-07-31 Rhone Poulenc Sa Nouveaux dérivés de la naphtyridine et leur procédé de préparation.

Also Published As

Publication number Publication date
AU503200B2 (en) 1979-08-30
ATA848675A (de) 1977-09-15
YU281575A (en) 1983-01-21
NL7512732A (nl) 1976-05-11
CY1045A (en) 1980-08-01
AR208800A1 (es) 1977-02-28
DD122684A5 (en:Method) 1976-10-20
AR208414A1 (es) 1976-12-27
HK19380A (en) 1980-04-18
DE2550111A1 (de) 1976-05-13
CA1057755A (fr) 1979-07-03
NO753713L (en:Method) 1976-05-10
BE835325A (fr) 1976-05-06
GB1468497A (en) 1977-03-30
LU73738A1 (en:Method) 1976-09-06
US4220646A (en) 1980-09-02
IL48423A0 (en) 1976-01-30
AU8633175A (en) 1977-05-12
CS598377A2 (en) 1984-01-16
IE41928L (en) 1976-05-07
SU673173A3 (ru) 1979-07-05
CS231958B2 (en) 1985-01-16
YU39583B (en) 1985-03-20
CS751075A2 (en) 1984-01-16
CS231957B2 (en) 1985-01-16
IE41928B1 (en) 1980-04-23
ATA401977A (de) 1977-10-15
FI753127A7 (en:Method) 1976-05-08
DK141098C (en:Method) 1980-07-07
YU40087B (en) 1985-06-30
SE407063B (sv) 1979-03-12
HU173108B (hu) 1979-02-28
NO143576B (no) 1980-12-01
FI60707B (fi) 1981-11-30
JPS5498790A (en) 1979-08-03
IL48423A (en) 1979-03-12
DK499275A (en:Method) 1976-05-08
JPS5170776A (en:Method) 1976-06-18
SE7512477L (sv) 1976-05-10
JPS558508B2 (en:Method) 1980-03-04
NL177405B (nl) 1985-04-16
SU604496A3 (ru) 1978-04-25
NL177405C (nl) 1985-09-16
DE2550111C2 (de) 1983-09-15
AT343123B (de) 1978-05-10
NO143576C (no) 1981-03-11
OA05162A (fr) 1981-01-31
AT343666B (de) 1978-06-12
FI60707C (fi) 1982-03-10
YU192182A (en) 1983-01-21
JPS5422996B2 (en:Method) 1979-08-10
DK141098B (da) 1980-01-14
CH609057A5 (en:Method) 1979-02-15

Similar Documents

Publication Publication Date Title
PL101248B1 (pl) Sposob wytwarzania nowych pochodnych piroliny
US5461062A (en) Condensed imidazopyridine derivatives
AU708750B2 (en) 6-substituted pyrazolo {3,4-d} pyrimidin-4-ones and compositions and methods of use thereof
CA2258885A1 (en) Tricyclic benzazepine vasopressin antagonists
SK50496A3 (en) Pyridazindiones, producing method thereof and pharmaceutical compositions containing them
SK33995A3 (en) Imidazodiazepines
EP0655451B1 (en) Tetracyclic condensed heterocyclic compounds for the treatment of senile dementia
Al-Thebeiti Synthesis of some new thiazolo [3, 2-a] pyridines and related heterocyclic systems
CS251790B2 (en) Method of pyrrole's new condensed derivatives production
EP0126970A2 (en) Anxiolytic and anti-depressant thienopyridine derivatives
Forbes et al. Synthesis and evaluation of a series of aryl [e] fused pyrazolo [4, 3-c] pyridines with potential anxiolytic activity
EP2188285A1 (en) Pyrazoloquinoline and pyrazolonaphthyridine derivatives as gaba alpha ligands
US4705793A (en) Pyrazolo[3,4-b]pyrrolo[3,4-e]pyridine-5(1H)-one and 1-H-pyrazolo[3,4-b][1,6]naphthyridine-5(6H)-one derivations, useful as anti-anxiety agents
SK37394A3 (en) 1,8-benzonaphthyridine derivatives, method of their preparation and compositions containing these derivatives
FI63405B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara imdazo(1,5-a)(1,4)diazepin-foereningar
WO2009021957A2 (en) Tricyclic heterocyclic compounds as gaba a modulators
EP1150983A1 (en) Triazolo-pyridazine derivatives as ligands for gaba receptors
Khan et al. Condensed heterocycles: synthesis and antifungal activity of. pi.-deficient pyrimidines linked with. pi.-rich heterocycles
GUEIFFIER et al. Synthesis of 1H-imidazo [1, 2-a] pyrazolo [3, 4-c] pyridines
PL100184B1 (pl) Sposob wytwarzania nowych pochodnych naftyrydynylo-piroliny
Makki et al. Synthesis and Biological Evaluation of New Fused Thiazolo [4, 5‐d] Pyridazine Derivatives
SU980622A3 (ru) Способ получени производных пиридо /1,2-а/ пиримидина или их оптических изомеров, или их гидратов, или их солей
Massa et al. Research on nitrogen heterocyclic compounds. XV. Synthesis of 1H, 4H‐pyrazolo [4, 3f] pyrrolo [1, 2‐a][1, 4] diazepine derivatives
AU703635B2 (en) Anellated beta-carbolines
EP0039920A2 (en) Triazaloquinoxalin-1,4-diones